Bone marrow-derived cells in ocular neovascularization: contribution and mechanisms

Area of Science:

• Ophthalmology
• Cell Biology
• Immunology

Background:

• Ocular neovascularization is a leading cause of vision impairment.
• Bone marrow-derived cells (BMCs) are increasingly recognized for their significant role in ocular neovascularization.
• The precise mechanisms of BMC involvement are under active investigation.

Purpose of the Study:

• To review the contribution of BMCs to ocular neovascularization.
• To elucidate the mechanisms mediating BMC effects on neovascularization progression.
• To highlight recent advancements, particularly from our laboratory.

Main Methods:

• Review of existing literature on BMCs in ocular neovascularization.
• Analysis of the four phases of BMC participation: mobilization, migration, adhesion, and differentiation.
• Examination of regulatory factors including cytokines and adhesion molecules.

Main Results:

• BMCs are mobilized by factors like VEGF, G-CSF, and EPO.
• Cytokines (SDF-1, TNF-α, VEGF) regulate BMC migration.
• Adhesion molecules (VCAM-1, ICAM-1, VE-cadherin) mediate BMC adhesion.
• Mechanisms of BMC differentiation remain largely unknown.
• BMCs secrete cytokines influencing the ocular microenvironment, potentially aggravating neovascularization.

Conclusions:

• BMCs are integral to ocular neovascularization development through a complex regulatory network.
• Further understanding of BMC mechanisms is essential for developing novel therapies.
• Targeting BMCs presents a promising avenue for treating vision-threatening eye conditions.